GreenLight Biosciences has partnered with the non-profit scientific research organization IAVI to work together on a Phase I clinical trial in Africa. IAVI and its partners were among the first to conduct HIV
Psychedelic drug discovery company Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) obtained FDA approval to start the first clinical trial using naturally-sourced psychedelic substances.